Vera Gorbunova

Department of Biology, University of Rochester

Affiliated withUniversity of Rochester University of Rochester

Research Area

Biography

Vera Gorbunova has not added Biography.
If you are Vera Gorbunova and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 115	2010
Publication title Cited by 299	2010

Other Publications

Article	Year
CLK-1 protein has DNA binding activity specific to O(L) region of mitochondrial DNA. FEBS letters\| PubMed ID: 11959146	2002
Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. The Journal of biological chemistry\| PubMed ID: 12140282	2002
Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts. The Journal of biological chemistry\| PubMed ID: 12496279	2003
Selectable system for monitoring the instability of CTG/CAG triplet repeats in mammalian cells. Molecular and cellular biology\| PubMed ID: 12808091	2003
Telomerase as a growth-promoting factor. Cell cycle (Georgetown, Tex.)\| PubMed ID: 14504469	2003
Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cance... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 14722035	2004
DNA end joining becomes less efficient and more error-prone during cellular senescence. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 15123826	2004
Genome-wide demethylation destabilizes CTG.CAG trinucleotide repeats in mammalian cells. Human molecular genetics\| PubMed ID: 15459182	2004
Making ends meet in old age: DSB repair and aging. Mechanisms of ageing and development\| PubMed ID: 15888314	2005
Cell divisions are required for L1 retrotransposition. Molecular and cellular biology\| PubMed ID: 17145770	2007
Telomerase activity coevolves with body mass not lifespan. Aging cell\| PubMed ID: 17173545	2007
TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17670947	2007
Changes in the level and distribution of Ku proteins during cellular senescence. DNA repair\| PubMed ID: 17686666	2007
Changes in DNA repair during aging. Nucleic acids research\| PubMed ID: 17913742	2007
Genome-wide demethylation promotes triplet repeat instability independently of homologous recombination. DNA repair\| PubMed ID: 18083071	2008
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet\| PubMed ID: 18156031	2007
Coevolution of telomerase activity and body mass in mammals: from mice to beavers. Mechanisms of ageing and development\| PubMed ID: 18387652	2009
Comparison of nonhomologous end joining and homologous recombination in human cells. DNA repair\| PubMed ID: 18675941	2008
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell cycle (Georgetown, Tex.)\| PubMed ID: 18769152	2008
Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging cell\| PubMed ID: 18778411	2008
Use of the Rad51 promoter for targeted anti-cancer therapy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19106292	2008
Rodents for comparative aging studies: from mice to beavers. Age (Dordrecht, Netherlands)\| PubMed ID: 19424861	2008
DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia (New York, N.Y.)\| PubMed ID: 19568413	2009
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published t... Onkologie\| PubMed ID: 19745590	2009
Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19858485	2009
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20159816	2010
SIRT6 promotes DNA repair under stress by activating PARP1. Science (New York, N.Y.)\| PubMed ID: 21680843	2011
SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell cycle (Georgetown, Tex.)\| PubMed ID: 21900744	2011
Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. Aging\| PubMed ID: 21946623	2011
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22008909	2012
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet\| PubMed ID: 22056247	2011
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO1939... Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 22173662	2012
Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells. PloS one\| PubMed ID: 22174876	2011
SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Preventive medicine\| PubMed ID: 22178470	2011
Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics\| PubMed ID: 22188361	2012